Alpha-1 Antitrypsin Deficiency and Lung Cancer Risk: A Case–Control Study in Never-Smokers
暂无分享,去创建一个
A. Fernández-Villar | A. Ruano-Raviña | M. Provencio | J. Barros-Dios | F. González-Barcala | C. Montero-Martínez | O. Castro-Añón | C. Peña | M. Torres-Durán | V. Leiro-Fernández | I. Parente-Lamelas | J. Abal-Arca | A. Golpe-Gómez | Cristina Martínez | Rosirys Guzmán-Taveras | M. Mejuto-Martí | O. Castro‐Añón
[1] C. la Vecchia,et al. European cancer mortality predictions for the year 2017, with focus on lung cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] A. Fernández-Villar,et al. Lung cancer in never-smokers: a case–control study in a radon-prone area (Galicia, Spain) , 2014, European Respiratory Journal.
[3] A. Fernández-Villar,et al. Residential radon and lung cancer in never smokers. A systematic review. , 2014, Cancer letters.
[4] C. la Vecchia,et al. European cancer mortality predictions for the year 2014. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] F. D. de Serres,et al. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema , 2011, Orphanet journal of rare diseases.
[6] D. Radojkovic,et al. Alpha-1-antitrypsin Phenotypes and Neutrophil Elastase Gene Promoter Polymorphisms in Lung Cancer , 2011, Pathology & Oncology Research.
[7] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[8] William Pao,et al. Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications , 2009, Clinical Cancer Research.
[9] E. Chan,et al. α‐1‐Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood , 2009, Journal of leukocyte biology.
[10] F. D. de Serres,et al. Long-term augmentation therapy with alpha-1 antitrypsin in an MZ-AAT severe persistent asthma. , 2008, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[11] W. Bamlet,et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. , 2008, Archives of internal medicine.
[12] I. G. Clausen,et al. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. , 2008, The international journal of biochemistry & cell biology.
[13] A. Gazdar,et al. Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.
[14] D. DeMeo,et al. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency , 2007, Thorax.
[15] S. Vedal,et al. Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency , 2006, International journal of chronic obstructive pulmonary disease.
[16] Z. Jelić-Ivanović,et al. Association of moderate alpha-1 antitrypsin deficiency with lung cancer in the Serbian population. , 2006, Archives of medical research.
[17] M. Nusier,et al. Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients. , 2006, Saudi medical journal.
[18] L. Melton,et al. α1-Antitrypsin and Neutrophil Elastase Imbalance and Lung Cancer Risk , 2005 .
[19] L. Melton,et al. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. , 2005, Chest.
[20] F. D. de Serres,et al. alpha1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia. , 2005, Medical hypotheses.
[21] I. Blanco,et al. Déficit de alfa-1-antitripsina en España (variantes deficientes PI*S y PI*Z): prevalencia estimada y número de sujetos calculados para cada fenotipo , 2004 .
[22] D. Lomas,et al. α1-Antitrypsin deficiency • 4: Molecular pathophysiology , 2004, Thorax.
[23] Zhifu Sun,et al. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. , 2004, The Lancet. Oncology.
[24] D. Lomas,et al. Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. , 2004, Thorax.
[25] F. D. de Serres,et al. [PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain]. , 2004, Medicina clinica.
[26] S. Marcus,et al. Activation of progelatinase A (MMP‐2) by neutrophil elastase, cathepsin G, and proteinase‐3: A role for inflammatory cells in tumor invasion and angiogenesis , 2001, Journal of cellular physiology.
[27] I. Blanco,et al. Alpha1-antitrypsin Pi phenotypes S and Z in Spain: an analysis of the published surveys. , 2001, Respiratory medicine.
[28] R. Strausberg,et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] I. Blanco,et al. [Allelic frequency of the gene of alpha-1-antitrypsin in the general population in a county in Asturias]. , 1999, Medicina clinica.
[30] T. Lesnick,et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] D. Hutchison. Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. , 1998, Respiratory medicine.
[32] D. Lomas,et al. Alpha 1-antitrypsin deficiency. A conformational disease. , 1996, Chest.
[33] M. Miravitlles,et al. [Study of the frequency of different phenotypes of alpha-1-antitrypsin in a population of Barcelona]. , 1996, Medicina clinica.
[34] André Mj,et al. [Evaluation of alpha 1-antitrypsin phenotypes in Castilla-León: study of a population of newborn infants]. , 1989 .
[35] M. L. Arranz Peña,et al. [Evaluation of alpha 1-antitrypsin phenotypes in Castilla-León: study of a population of newborn infants]. , 1989, Revista clinica espanola.
[36] M. Fagerhol,et al. Serum Pi types in some European, American, Asian and African populations. , 2009, Acta pathologica et microbiologica Scandinavica.
[37] C. Laurell,et al. The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency , 1963 .